Skip to main content
. 2021 Jun 11;44(7):811–823. doi: 10.1007/s40264-021-01076-w

Fig. 1.

Fig. 1

Unsolicited adverse events (AEs). auto-HSCT(I/II) autologous hematopoietic stem cell transplant recipients (phase I/II), auto-HSCT(III) autologous hematopoietic stem cell transplant recipients (phase III), HIV human immunodeficiency virus-infected adults, HM hematologic malignancies patients, RT renal transplant recipients, RZV adjuvanted recombinant zoster vaccine, ST solid tumors patients